Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Join us as we explore how Cipla is driving resilience and agility through large-scale digital transformation, sharing key lessons and insights from their remarkable journey. Digital transformation ...

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla has launched a mobile application, CipAir, to aid in asthma screening in India, aiming to address the country's high asthma burden and underdiagnosis. India's pharmaceutical industry is poised ...

Cipla's North American business achieved a record $250 million revenue in Q1 FY25, a 13% year-on-year growth. The company's branded prescription business in India grew 10%, while overall India growth ...

Return on investment - most recent fiscal year 16.16 ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

With From season 3 now available in the UK, everyone has been left stunned by that explosive ending. Thankfully, the show has been renewed for season 4, with that season 3 ending giving us a hint ...